⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

TWST

Twist Bioscience Corporation

Healthcare · Biotechnology

125.52USD

-2.5400 (-1.98%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$-0.03▼$010
Next quarter$-0.05▼$011
Current year$-0.6▼$020
Next year$-0.63▲$-2.0511

Recent quarters

Beat in 2 of the last 4

QuarterEstimateActualSurprise
2026-06-30$-0.18$-0.56-0.38 (-212.4%)
2026-03-31$-0.53$-0.6-0.07 (-12.6%)
2025-12-31$-0.52$-0.5+0.02 (+3.8%)
2025-09-30$-0.5$-0.45+0.05 (+10.0%)

Wall Street coverage

95 ratings from 19 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
BWS FinancialInitiatedSell$45Sep 9, 2026
UBSInitiatedNeutral$144Sep 9, 2026
Piper SandlerMaintainedOverweight$85 $115Aug 5, 2026
BairdMaintainedOutperform$113 $115Aug 4, 2026
Canaccord GenuityMaintainedBuy$90 $120Jul 14, 2026
Evercore ISI GroupDowngraded from OutperformIn-Line$66 $102Jul 6, 2026
GuggenheimMaintainedBuy$60 $107Jun 29, 2026
BarclaysMaintainedOverweight$65 $95Jun 24, 2026
TD CowenMaintainedBuy$68 $89Jun 15, 2026
Canaccord GenuityInitiatedBuy$90Jun 15, 2026
Piper SandlerInitiatedOverweight$85Jun 11, 2026
Leerink PartnersUpgraded from Market PerformOutperform$70May 5, 2026
BarclaysMaintainedOverweight$55 $65May 5, 2026
GuggenheimMaintainedBuy$55 $60May 5, 2026
BairdMaintainedOutperform$50 $65May 5, 2026
BarclaysMaintainedOverweight$50 $55Apr 14, 2026
Evercore ISI GroupMaintainedOutperform$52 $56Apr 6, 2026
GuggenheimMaintainedBuy$50 $55Mar 30, 2026
Evercore ISI GroupMaintainedOutperform$42 $52Feb 3, 2026
BarclaysMaintainedOverweight$39 $50Feb 3, 2026
GuggenheimMaintainedBuy$42 $50Jan 26, 2026
TD CowenMaintainedBuy$32 $43Jan 8, 2026
BarclaysMaintainedOverweight$37 $39Dec 15, 2025
BarclaysMaintainedOverweight$40 $37Nov 17, 2025
Stephens & Co.InitiatedOverweight$41Nov 4, 2025

Insider transactions

161 filings from 13 insiders · 11 buy / 66 sell over 6m

Officers and directors of TWST, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
LEPROUST EMILY MChief Executive OfficerSell41.6k$150.56$6.32MAug 25, 2026
WERNER ROBERT F.OfficerSell1.5k$139.07$213kAug 24, 2026
FINN PATRICK JOHNPresidentSell4.0k$139.07$563kAug 21, 2026
LEPROUST EMILY MChief Executive OfficerSell6.6k$139.07$923kAug 21, 2026
GREEN PAULAOfficerSell1.4k$139.07$189kAug 21, 2026
LAPONIS ADAMChief Financial OfficerSell2.0k$139.07$273kAug 21, 2026
CHO DENNISOfficerSell1.6k$139.07$222kAug 21, 2026
CHO DENNISOfficerSell14.2k$129.75$1.84MAug 19, 2026
FINN PATRICK JOHNPresidentSell78.4k$115.90$9.22MAug 18, 2026
FINN PATRICK JOHNPresidentExercise23.4k$67.85$1.58MAug 18, 2026
BLAKE KATRYN SHINEMANDirectorSell2.2k$122.88$275kAug 12, 2026
LEPROUST EMILY MChief Executive OfficerSell20.0k$125.08$2.50MAug 12, 2026
LEPROUST EMILY MChief Executive OfficerExercise20.0k$26.66$532kAug 12, 2026
LEPROUST EMILY MChief Executive OfficerSell113.3k$125.16$14.18MAug 10, 2026
LEPROUST EMILY MChief Executive OfficerExercise113.3k$26.66$3.02MAug 10, 2026
CHESS ROBERT BRUCEDirectorSell18.4k$110.89$2.04MAug 7, 2026
CHESS ROBERT BRUCEDirectorExercise18.4k$11.89$219kAug 7, 2026
CHO DENNISOfficerSell14.2k$109.75$1.56MAug 5, 2026
FINN PATRICK JOHNPresidentSell2.9k$85.32$246kAug 3, 2026
GREEN PAULAOfficerSell1.1k$85.32$97kAug 3, 2026

Analyst Notes

Sign in to write

No analyst notes on TWST yet.

Analyst Ratings

10 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current27200Buy2.00
1 mo ago27200Buy2.00
2 mo ago27200Buy2.00
3 mo ago28100Buy1.91
Price target$108.60$36.00 – $148.00
-13.5% to target